Swiss National Bank Invitae Corp Transaction History

Swiss National Bank

$143 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$1.2 - $2.73 $49,800 - $113,295	-41,500 Reduced 7.69%	498,100 $672,000
Q4 2022 Feb 08, 2023	BUY	$1.71 - $3.61 $39,501 - $83,391	23,100 Added 4.47%	539,600 $1 Million
Q3 2022 Nov 09, 2022	BUY	$1.9 - $8.63 $18,810 - $85,437	9,900 Added 1.95%	516,500 $1.27 Million
Q2 2022 Aug 09, 2022	BUY	$2.13 - $9.01 $53,037 - $224,349	24,900 Added 5.17%	506,600 $1.24 Million
Q1 2022 May 09, 2022	BUY	$6.28 - $15.59 $322,792 - $801,326	51,400 Added 11.95%	481,700 $3.84 Million
Q4 2021 Feb 08, 2022	BUY	$14.7 - $28.67 $483,630 - $943,243	32,900 Added 8.28%	430,300 $6.57 Million
Q3 2021 Nov 08, 2021	BUY	$24.31 - $33.6 $707,421 - $977,760	29,100 Added 7.9%	397,400 $11.3 Million
Q2 2021 Aug 06, 2021	SELL	$26.09 - $40.4 $926,195 - $1.43 Million	-35,500 Reduced 8.79%	368,300 $12.4 Million
Q1 2021 May 07, 2021	BUY	$33.06 - $56.93 $3.48 Million - $5.99 Million	105,300 Added 35.28%	403,800 $15.4 Million
Q4 2020 Feb 05, 2021	BUY	$39.09 - $57.4 $594,168 - $872,480	15,200 Added 5.37%	298,500 $12.5 Million
Q3 2020 Nov 09, 2020	BUY	$28.43 - $44.67 $707,907 - $1.11 Million	24,900 Added 9.64%	283,300 $12.3 Million
Q2 2020 Aug 05, 2020	BUY	$11.71 - $30.29 $912,209 - $2.36 Million	77,900 Added 43.16%	258,400 $7.83 Million
Q1 2020 May 08, 2020	BUY	$7.64 - $27.5 $56,536 - $203,500	7,400 Added 4.27%	180,500 $2.47 Million
Q4 2019 Feb 06, 2020	BUY	$15.02 - $20.57 $193,758 - $265,353	12,900 Added 8.05%	173,100 $2.79 Million
Q3 2019 Nov 12, 2019	BUY	$18.85 - $27.5 $160,225 - $233,750	8,500 Added 5.6%	160,200 $3.09 Million
Q2 2019 Aug 02, 2019	BUY	$17.37 - $26.27 $57,321 - $86,691	3,300 Added 2.22%	151,700 $3.57 Million
Q1 2019 May 10, 2019	BUY	$10.65 - $25.75 $604,920 - $1.46 Million	56,800 Added 62.01%	148,400 $3.48 Million
Q4 2018 Feb 13, 2019	BUY	$9.26 - $16.38 $34,262 - $60,605	3,700 Added 4.21%	91,600 $1.01 Million
Q3 2018 Nov 08, 2018	BUY	$7.54 - $18.31 $35,438 - $86,057	4,700 Added 5.65%	87,900 $1.47 Million
Q1 2018 May 04, 2018	BUY	$4.69 - $10.05 $93,800 - $201,000	20,000 Added 31.65%	83,200 $390,000
Q4 2017 Feb 07, 2018	BUY	$7.86 - $9.99 $92,748 - $117,882	11,800 Added 22.96%	63,200 $574,000
Q3 2017 Nov 03, 2017	BUY	$8.89 - $10.4 $456,946 - $534,560	51,400	51,400 $482,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

2.12M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account